Details

---

• Active Ingredient: Each tablet contains 50 mg of clomifene citrate.

• Manufacturer: Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011 Limassol, Cyprus.

• Registration in Malaysia: Registered with the National Pharmaceutical Regulatory Agency (NPRA) under registration number MAL19870696AZ.

Indications

• Ovulatory Failure: Indicated for the treatment of ovulatory failure in women desiring pregnancy.

• Polycystic Ovary Syndrome (PCOS): Used in the management of PCOS-related infertility.

• Secondary Amenorrhea: Helps in restoring ovulation in cases of secondary amenorrhea.

Instructions for Use

• Dosage:

  • First Course: 50 mg (1 tablet) daily for 5 days.

  • Second Course: If ovulation does not occur after the first course, increase to 100 mg (2 tablets) daily for 5 days.

  • Maximum Courses: Up to 3 courses if ovulation does not occur; up to 6 courses if ovulation occurs but pregnancy is not achieved.

• Administration: Take orally with or without food. Swallow tablets whole with a drink of water; do not crush or chew.

• Monitoring: Regular monitoring is recommended during treatment to assess response and adjust dosage if necessary.